Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?

J Dermatol Sci. 2005 Mar;37(3):180-1. doi: 10.1016/j.jdermsci.2004.11.008. Epub 2005 Jan 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Topical
  • Alleles
  • Clinical Trials as Topic
  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / pharmacology
  • Dihydroxycholecalciferols / administration & dosage*
  • Dihydroxycholecalciferols / pharmacology
  • Gene Frequency
  • Genotype*
  • Homozygote
  • Humans
  • Polymorphism, Genetic
  • Psoriasis / drug therapy*
  • Psoriasis / genetics*
  • Receptors, Calcitriol / genetics*
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Dihydroxycholecalciferols
  • Receptors, Calcitriol
  • 1 alpha,24-dihydroxyvitamin D3